Skip to main content
SpringerLink
Log in

Be aware of the risks of nephrotoxicity when prescribing amoxicillin and third-generation cephalosporins

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Amoxicillin and third-generation cephalosporins are widely used in the prevention and treatment of established infections. These broad-spectrum antibiotics are mainly excreted via urine and are considered relatively safe. However, several reports have indicated that substantial nephrotoxicity (e.g. acute interstitial nephritis and crystal nephropathy) occurs with amoxicillin and several cases of nephrotoxicity have been reported with ceftriaxone. While corticosteroids have been shown to improve kidney function in some patients with acute interstitial nephritis, close monitoring of kidney function for acute kidney injury can lead to an early diagnosis and recovery. Strategies preventing acute kidney injury can also be implemented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Garnier A-S, Drablier G, Briet M, et al. Nephrotoxicity of amoxicillin and third-generation cephalosporins: an updated review. Drug Saf. 2023;46(8):715–24.

    Article  CAS  PubMed  Google Scholar 

  2. Garnier AS, Dellamaggiore J, Brilland B, et al. High incidence of amoxicillin-induced crystal nephropathy in patients receiving high dose of intravenous amoxicillin. J Clin Med. 2020;9(7):2022.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Daudon M, Frochot V, Bazin D, et al. Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment. Drugs. 2018;78(2):163–201.

    Article  CAS  PubMed  Google Scholar 

  4. Morales-Alvarez MC. Nephrotoxicity of antimicrobials and antibiotics. Adv Chronic Kidney Dis. 2020;27(1):31–7.

    Article  PubMed  Google Scholar 

  5. Muriithi AK, Leung N, Valeri AM, et al. Biopsy-proven acute interstitial nephritis, 1993–2011: a case series. Am J Kidney Dis. 2014;64:558–66.

    Article  PubMed  Google Scholar 

  6. Zeller V, Puyraimond-Zemmour D, Sené T, et al. Amoxicillin crystalluria, an emerging complication with an old and well-known antibiotic. Antimicrob Agents Chemother. 2016;60:3248.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Vodovar D, Thomas L, Mongardon N, et al. Dramatic increase of amoxicillin-induced crystal nephropathy found in a cohort study of French pharmacovigilance centers. Antimicrob Agents Chemother. 2018;62(3):e01630-e1717.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Thomas L, Beller C, Trenque T, et al. Amoxicillin-induced crystal nephropathy: a nationwide French pharmacovigilance databases study. Br J Clin Pharmacol. 2020;86(11):2256–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Grasberger H, Otto B, Loeschke K. Ceftriaxone-associated nephrolithiasis. Ann Pharmacother. 2000;34:1076–7.

    Article  CAS  PubMed  Google Scholar 

  10. Avci Z, Koktener A, Uras N, et al. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children. Arch Dis Child. 2004;89:1069–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ustyol L, Bulut MD, Agengin K, et al. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: a prospective study in 154 children. Hum Exp Toxicol. 2017;36:547–53.

    Article  CAS  PubMed  Google Scholar 

  12. Neuman G, Boodhan S, Wurman I, et al. Ceftriaxone-induced immune hemolytic anemia. Ann Pharmacother. 2014;48:1594–604.

    Article  PubMed  Google Scholar 

  13. Perazella MA, Markowitz GS. Drug-induced acute interstitial nephritis. Nat Rev Nephrol. 2010;6:461–70.

    Article  CAS  PubMed  Google Scholar 

  14. Ivanyi B, Olsen S. Tubulitis in renal disease. Curr Top Pathol. 1995;88:117–43.

    CAS  PubMed  Google Scholar 

  15. National Library of Medicine. Interstitial nephritis. 2023. https://medlineplus.gov/ency/article/000464.htm. Accessed 28 Feb 2024.

  16. González E, Gutiérrez E, Galeano C, et al. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int. 2008;73:940–6.

    Article  PubMed  Google Scholar 

  17. John Hopkins Medicine. Glomerulosclerosis. 2024. https://www.hopkinsmedicine.org/health/conditions-and-diseases/glomerulosclerosis. Accessed 28 Feb 2024.

Download references

Author information

Authors and Affiliations

  1. Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand

    Amy Zhuang-Yan

Authors
  1. Amy Zhuang-Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amy Zhuang-Yan.

Ethics declarations

Funding

The preparation of this review was not supported by any external funding.

Authorship and conflict of interest

A. Zhuang-Yan is a salaried employee of Adis International Ltd/Springer Nature and declares no relevant conflicts of interest. All authors contributed to this article and are responsible for its content.

Ethics approval, Consent to participate, Consent for publication, Availability of data and material, Code availability

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhuang-Yan, A. Be aware of the risks of nephrotoxicity when prescribing amoxicillin and third-generation cephalosporins. Drugs Ther Perspect 40, 127–130 (2024). https://doi.org/10.1007/s40267-024-01060-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40267-024-01060-1

Search

Navigation